DK440887D0 - Dopamin-beta-hydroxylase-inhibitorer - Google Patents

Dopamin-beta-hydroxylase-inhibitorer

Info

Publication number
DK440887D0
DK440887D0 DK440887A DK440887A DK440887D0 DK 440887 D0 DK440887 D0 DK 440887D0 DK 440887 A DK440887 A DK 440887A DK 440887 A DK440887 A DK 440887A DK 440887 D0 DK440887 D0 DK 440887D0
Authority
DK
Denmark
Prior art keywords
dopamine
beta
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
DK440887A
Other languages
English (en)
Other versions
DK440887A (da
Inventor
Joseph Alan Finkelstein
Lawrence Ivan Kruse
Thomas Brent Leonard
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK440887D0 publication Critical patent/DK440887D0/da
Publication of DK440887A publication Critical patent/DK440887A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK440887A 1986-08-28 1987-08-24 Dopamin-beta-hydroxylase-inhibitorer DK440887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/901,120 US4761415A (en) 1986-08-28 1986-08-28 Dopamine-β-hydroxylase inhibitors

Publications (2)

Publication Number Publication Date
DK440887D0 true DK440887D0 (da) 1987-08-24
DK440887A DK440887A (da) 1988-02-29

Family

ID=25413629

Family Applications (1)

Application Number Title Priority Date Filing Date
DK440887A DK440887A (da) 1986-08-28 1987-08-24 Dopamin-beta-hydroxylase-inhibitorer

Country Status (7)

Country Link
US (1) US4761415A (da)
EP (1) EP0261804A1 (da)
JP (1) JPS6363670A (da)
AU (1) AU7760987A (da)
DK (1) DK440887A (da)
PT (1) PT85596B (da)
ZA (1) ZA876394B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors
WO1989006125A1 (en) * 1987-12-31 1989-07-13 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
WO2004070352A2 (en) 2003-01-30 2004-08-19 Applera Corporation Methods, mixtures, kits and compositions pertaining to analyte determination
US20050148771A1 (en) 2004-01-05 2005-07-07 Applera Corporation. Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
US7355045B2 (en) 2004-01-05 2008-04-08 Applera Corporation Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof
EP2822936B1 (en) 2012-03-07 2021-09-08 The McLean Hospital Corporation Aminoquinoline derivatives and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131192C (da) * 1965-06-16
NL131212C (da) * 1967-09-11
US4271308A (en) * 1968-09-04 1981-06-02 Rohm And Haas Company 4-alkyl-1,2,4-4H-triazole derivatives
US4120864A (en) * 1970-08-26 1978-10-17 Rohm And Haas Company 1,2,4-4H-triazole derivatives
US3937713A (en) * 1974-03-07 1976-02-10 Eli Lilly And Company Process for the preparation of s-triazolo[3,4-b]benzothiazoles
US4082762A (en) * 1975-08-25 1978-04-04 Eli Lilly And Company 4-(2-halophenyl)-1,2,4-triazole-3-thiol compounds
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors

Also Published As

Publication number Publication date
US4761415A (en) 1988-08-02
DK440887A (da) 1988-02-29
ZA876394B (en) 1988-11-30
EP0261804A1 (en) 1988-03-30
JPS6363670A (ja) 1988-03-22
PT85596B (en) 1989-11-30
AU7760987A (en) 1988-03-03
PT85596A (en) 1987-09-01

Similar Documents

Publication Publication Date Title
ATA13587A (de) Sportschuh
DK436987D0 (da) Gel-forpakning
DK692487D0 (da) Pibe
DK293088A (da) Inhibitorer af dopamin-beta-hydroxylase
DK440887D0 (da) Dopamin-beta-hydroxylase-inhibitorer
ZA873653B (en) Dopamine-beta-hydroxylase inhibitors
DK246387A (da) Roergennemfoering
DK163088D0 (da) Dopamin-beta-hydroxylase inhibitor
FI875615A (fi) Segmenttimäärittelijäyksikkö
DK440989A (da) Dopamin-beta-hydroxylase inhibitorer
AT386436B (de) Schachtsystem
ATA48386A (de) Kranbahn
KR880010041U (ko) 파이프류의 지착구
NO881638D0 (no) Dopamin-beta-hydroksylase-inhibitorer.
DK178788D0 (da) Inhibitorer af dopamin-beta-hydroxylase
SE8603968D0 (sv) New use
DK80586D0 (da) Udmugningsanlaeg
DK439786D0 (da) Mosafviser/fjerner
BR6600893U (pt) Aiveca
BR6601490U (pt) Aiveca
BR6601361U (pt) Marmiteira
BR6601341U (pt) Bilboque
BR6601281U (pt) Aeromodelo
BR6601164U (pt) Poster-postal
BR6601142U (pt) Punho-colchao

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment